Antiangiogenic therapy combined with TACE - more beneficial therapeutic effect in HCC.
Wang
Z
Z
Li
Z
Z
D020533:Angiogenesis Inhibitors / Q000008:administration & dosage*; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy* / Q000401:mortality; D016461:Chemoembolization, Therapeutic; D004359:Drug Therapy, Combination; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy*; D015996:Survival Rate; D013792:Thalidomide / Q000008:administration & dosage*
D020533:Angiogenesis Inhibitors; D013792:Thalidomide